{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:54:39Z","timestamp":1786366479180,"version":"build-2736575974"},"reference-count":53,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.5144\/0256-4947.2014.407","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T06:17:33Z","timestamp":1490422653000},"page":"407-414","source":"Crossref","is-referenced-by-count":12,"title":["Polymorphisms of tumor necrosis factor-alpha and interleukin-6 gene and C-reactive protein profiles in patients with idiopathic dilated cardiomyopathy"],"prefix":"10.5144","volume":"34","author":[{"given":"Afrose","family":"Liaquat","sequence":"first","affiliation":[{"name":"From the Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul Zareen","family":"Asifa","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asyia","family":"Zeenat","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qamar","family":"Javed","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3134","reference":[{"issue":"5","key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 WHO\/International society and federation of cardiology task force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson P","year":"1996","journal-title":"Circulation"},{"issue":"23","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.0000100721.52503.85","article-title":"Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study","volume":"108","author":"Grimm W","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/hrt.73.5.417","article-title":"Familial dilated cardiomyopathy in the United Kingdom","volume":"73","author":"Keeling PJ","year":"1995","journal-title":"Br Heart J"},{"issue":"2","key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1631\/jzus.2006.B0167","article-title":"Genetics of complex diseases","volume":"7","author":"Motulsky AG","year":"2006","journal-title":"J Zhejiang Univ Sci B"},{"issue":"6","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/humu.1143","article-title":"First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy","volume":"17","author":"Hoffmann B","year":"2001","journal-title":"Hum Mutat"},{"issue":"18","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy","volume":"338","author":"Niimura H","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.jacc.2004.08.058","article-title":"Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy","volume":"44","author":"Hayashi T","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.0000018444.47798.94","article-title":"Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology","volume":"105","author":"Olson TM","year":"2002","journal-title":"Circulation"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev.cellbio.18.012502.105840","article-title":"Striated muscle cytoarchitecture: An Intricate Web of Form and Function","volume":"18","author":"Clark KA","year":"2002","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"8","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00059-004-2626-9","article-title":"Inflammation in dilated cardiomyopathy","volume":"29","author":"Pankuweit S","year":"2004","journal-title":"Herz"},{"issue":"9","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/hq0901.094280","article-title":"Interleukin-6 gene \u2212174g>c and \u2212572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery","volume":"21","author":"Brull DJ","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust P","year":"1999","journal-title":"Am J Cardiol"},{"issue":"8","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.103.8.1083","article-title":"Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study","volume":"103","author":"Skudicky D","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejheart.2003.09.005","article-title":"Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms","volume":"6","author":"Bahrmann P","year":"2004","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.trsl.2009.10.002","article-title":"Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients","volume":"155","author":"Hussain S","year":"2010","journal-title":"Transl Res"},{"issue":"2","key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America practice guideline","volume":"15","author":"Hershberger RE","year":"2009","journal-title":"J Card Fail"},{"issue":"2","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCGENETICS.109.912345","article-title":"Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy","volume":"3","author":"Hershberger RE","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1536\/jhj.41.183","article-title":"Polymorphisms of tumor necrosis factor-alpha and Interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy","volume":"41","author":"Ito M","year":"2000","journal-title":"Jpn Heart J"},{"issue":"2","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1388-9842(02)00238-6","article-title":"Tumor necrosis factor-alpha polymorphism in Turkish patients with dilated cardiomyopathy","volume":"5","author":"Alikasifoglu M","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cyto.2011.01.004","article-title":"Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy","volume":"54","author":"Adamopoulos S","year":"2011","journal-title":"Cytokine"},{"issue":"1","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0735-1097(99)00522-7","article-title":"Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: The CARDIGENE study","volume":"35","author":"Tiret L","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clinbiochem.2010.01.008","article-title":"Study of TNF alpha \u2212308G\/A and IL6 \u2212174G\/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population","volume":"43","author":"Bouhaha R","year":"2010","journal-title":"Clin Biochem"},{"issue":"9","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","article-title":"A genomewide association study identifies two loci associated with heart failure due to dilated cardiomyopathy","volume":"32","author":"Villard E","year":"2011","journal-title":"Eur Heart J"},{"issue":"3","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbadis.2009.01.007","article-title":"Tumor necrosis factor alpha \u2212308 gene locus promoter polymorphism: an analysis of association with health and disease","volume":"1792","author":"Elahi MM","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.thromres.2010.12.018","article-title":"Tumor necrosis factor-alpha G-308A gene polymorphism and coronary heart disease susceptibility: An updated meta-analysis","volume":"127","author":"Zhang HF","year":"2011","journal-title":"Thromb Res"},{"issue":"2","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.exger.2003.10.012","article-title":"The IL-6 \u2212174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans","volume":"39","author":"Bruunsgaard H","year":"2004","journal-title":"Exp Gerontol"},{"issue":"6","key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10522-005-4908-x","article-title":"Associations of the \u2212174 G\/C interleukin-6 gene promoter polymorphism with serum interleukin 6 and mortality in the elderly","volume":"6","author":"Ravaglia G","year":"2005","journal-title":"Biogerontology"},{"issue":"1","key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.atherosclerosis.2008.08.036","article-title":"Association of interleukin-6 (IL-6)-174G\/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking","volume":"204","author":"Panoulas VF","year":"2009","journal-title":"Atherosclerosis"},{"issue":"10","key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/dna.2010.1044","article-title":"Association of tumor necrosis factor gene polymorphisms with susceptibility to dilated cardiomyopathy in a Han Chinese population","volume":"29","author":"Liang WB","year":"2010","journal-title":"DNA Cell Biol"},{"issue":"5","key":"e_1_3_1_31_2","first-page":"254","article-title":"The G-308A polymorphism of the TNF-\u03b1 gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy","volume":"19","author":"Brooksbank R","year":"2008","journal-title":"Cardiovasc J Afr"},{"issue":"25","key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"e924","DOI":"10.1161\/CIRCULATIONAHA.105.583815","article-title":"South Asians and cardiovascular risk: what clinicians should know","volume":"113","author":"Gupta M","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(00)01121-8","article-title":"Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure","volume":"86","author":"Deliargyris EN","year":"2000","journal-title":"Am J Cardiol"},{"issue":"6","key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3346\/jkms.2003.18.6.791","article-title":"The origin of proinflammatorycytokines in patients with idiopathic dilated cardiomyopathy","volume":"18","author":"Chang HJ","year":"2003","journal-title":"J Korean Med Sci"},{"issue":"4","key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11886-000-0080-8","article-title":"Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation","volume":"2","author":"Ridker PM","year":"2000","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2796.2000.00701.x","article-title":"IL-6 and IL-1 receptor antagonist in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction","volume":"248","author":"Gabriel AS","year":"2000","journal-title":"J Intern Med"},{"issue":"18","key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/01.CIR.103.18.2260","article-title":"Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms","volume":"103","author":"Jones KG","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"e_1_3_1_38_2","first-page":"1237","article-title":"Association between 22 cytokine gene polymorphisms and dilated cardiomyopathy in Macedonian patients","volume":"67","author":"Spiroska V","year":"2009","journal-title":"Kardiol Pol"},{"issue":"4","key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine B","year":"1990","journal-title":"N Engl J Med"},{"issue":"5573","key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen G","year":"2002","journal-title":"Science"},{"issue":"3","key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0735-1097(99)00600-2","article-title":"The role of tumor necrosis factor in the pathophysiology of heart failure","volume":"35","author":"Feldman AM","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione G","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1165\/ajrcmb.22.2.f178","article-title":"Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family","volume":"22","author":"Kuwano K","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"18","key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"16304","DOI":"10.1074\/jbc.M212321200","article-title":"JAK2, STAT3, not ERK1\/2, mediates Interleukin 6 induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes","volume":"278","author":"Yu X","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jlb.66.4.562","article-title":"Impact of the \u2212308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease","volume":"66","author":"Abraham LJ","year":"1999","journal-title":"J Leukoc Biol"},{"issue":"20","key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1128\/MCB.25.20.9073-9081.2005","article-title":"GCF2\/LRRFIP1 represses tumor necrosis factor alpha expression","volume":"25","author":"Suriano AR","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"24","key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"18138","DOI":"10.1074\/jbc.M000379200","article-title":"Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation","volume":"275","author":"Terry CF","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-007-0184-8","article-title":"Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population","volume":"27","author":"Banerjee I","year":"2009","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.STR.0000194961.17292.33","article-title":"Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese: a case-control study","volume":"37","author":"Nakayama T","year":"2006","journal-title":"Stroke"},{"issue":"10","key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/01.STR.0000182242.59466.ee","article-title":"Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population","volume":"36","author":"Saleheen D","year":"2005","journal-title":"Stroke"},{"issue":"12","key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"Sabatine MS","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.ATV.18.9.1386","article-title":"C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries","volume":"18","author":"Torzewski J","year":"1998","journal-title":"Arteroscler Thromb Vasc Biol"},{"issue":"5","key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.vph.2006.02.002","article-title":"The TNF-\u03b1 G-308A polymorphism is associated with C-reactive protein levels: The Heritage Family Study","volume":"44","author":"Lakka HM","year":"2006","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1258\/acb.2010.090305","article-title":"The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6 \u2212174 G\/C gene polymorphism","volume":"47","author":"Wypasek E","year":"2010","journal-title":"Ann Clin Biochem"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/vol34\/vol34iss5\/742.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:04:30Z","timestamp":1559459070000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2014.407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.5144\/0256-4947.2014.407"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2014.407","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}